26,31 %The triple mutant HGEAA haplotype in Pfdhps had a prevalence of 26.31% in Kisumu and 44.68% in Kisii.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 14 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 125 / 268
26,31 %The triple mutant HGEAA haplotype in Pfdhps had a prevalence of 26.31% in Kisumu and 44.68% in Kisii.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 14 observations
82 casesIn the per-protocol analysis, 82 of 415 children in the RTS,S/AS01E group had a first or only clinical malaria episode by 12 months.
Kenyapaludismepublié 2011The Lancet. Infectious diseaseseurope_pmcdocument de 6 observationsDOI 10.1016/s1473-3099(10)70262-0
1 infective_bite_per_yearThe average number of infective bites received by children was still greater than one a year in hamlets where bednets were used.
Kenyapaludismepublié 1989Medical and veterinary entomologyeurope_pmcdocument de 7 observations
0,3 %The percentage of HIV infections with PrEP-associated nucleoside reverse transcriptase inhibitor (NRTI) drug resistance was 0.3% in the antibody rapid diagnostic testing scenario.
KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 6 observations
24 %Health facility blood smear results led to undertreatment of 24% of patients and overtreatment of 8% of patients compared to slide 2 (gold standard).
Kenyapaludismepublié 2026Malaria journalPubMeddocument de 10 observations
78 %78% of the participants preferred full disclosure of their HIV status by 12 years of age.
KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations
3,9 per_100_person_monthsThe overall rate of first viral rebound was 3.9 per 100 person-months in Nakuru.
KenyaVIH/sidapublié 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 9 observations
92 %Among HIV-infected children in Kenya, 92% were receiving antiretroviral therapy (ART) in 2018.
KenyaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 10 observations
49 %Candida albicans constituted 49.0% (n=24) of the total yeasts isolated.
Kenyayeast infectionpublié 2021The Pan African medical journaleurope_pmcdocument de 8 observations
49 %An intervention that halves the risk of malaria episodes would reduce the prevalence of iron deficiency in African children by 49%.
Kenyairon deficiency · paludismepublié 2021Nature medicineeurope_pmcdocument de 3 observations
8 countriesAnopheles stephensi has been identified in eight African countries as of 2025: Ethiopia, Sudan, Somaliland, Eritrea, Nigeria, Kenya, Ghana and Niger.
Kenyapaludismeobservé 2025publié 2026Scientific reportsPubMeddocument de 3 observations
32 559 participantsThe meta-analysis included 51 studies involving 32,559 participants on Chlamydia trachomatis in Kenya.
KenyaChlamydia trachomatispublié 2025BMC infectious diseasesPubMeddocument de 4 observations
3,64 prevalence_rate_ratioThe prevalence rate ratio for HIV counseling in intervention versus control facilities in the final study quarter was 3.64.
KenyaVIH/sidapublié 2022Implementation science : ISeurope_pmcdocument de 6 observationsDOI 10.1186/s13012-022-01242-3
75 %The sensitivity of the verbal autopsy technique was greater than 75% for measles, neonatal tetanus, malnutrition, and trauma-related deaths.
Kenyamalnutrition · neonatal tetanus · rougeole · trauma-related deathspublié 1992Lancet (London, England)europe_pmcdocument de 3 observations
85 %Most HIV-1 transmission clusters (85%) consisted of sequences from the same risk group.
KenyaVIH/sidaobservé 2005-2019publié 2020Scientific reportsPubMeddocument de 9 observations
78,7 %A majority (78.7%) of the 705 HIV patients had a history of opportunistic infections during their antiretroviral therapy lifetime.
KenyaVIH/sidapublié 2023BioMed research internationalPubMeddocument de 6 observations
55,9 %Among Kenyan adolescents aged 15–19 years in Kisumu with no prior PrEP use, boys were more willing than girls to consider using PrEP (55.9% vs. 49.7%).
KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 15 observations
65 %Approximately 65% of the cancer cases with known stage at diagnosis were in stages III and IV.
Kenyacancer (non précisé)publié 2025PloS oneeurope_pmcdocument de 7 observations
61 per_1000Overall prevalence for any neurological impairment decreased from 61 per 1000 in 2001 to 44.7 per 1000 in 2015.
Kenyaneurological impairmentobservé 2001publié 2022Developmental medicine and child neurologyeurope_pmcDOI 10.1111/dmcn.15059
201 casesAmong 740 livebirths, 201 (27.2%) were preterm.
Kenyapreterm birthpublié 2022AIDS (London, England)PubMeddocument de 10 observations
20,7 %20.7% of the studies on HCV in Kenya included injection drug users.
Kenyahépatite Cpublié 2024Journal of epidemiology and global healthPubMeddocument de 8 observations
91 %Evolution of drug resistance mutations was detected in 91% of 22 participants with short-term follow-up in a cohort of Kenyan children and adolescents living with HIV failing first-line antiretroviral therapy.
KenyaVIH/sidapublié 2023VirusesPubMeddocument de 6 observations
The number of bacterial vaginosis diagnoses in this cohort has decreased significantly over time.
Kenyavaginose bactériennepublié 2012AIDS (London, England)europe_pmcdocument de 3 observationsDOI 10.1097/qad.0b013e32834ed7f0
76 %Of 16,903 children surveyed, 76% were uninfected with Plasmodium falciparum and not febrile.
Kenyapaludismeobservé 2007–2009publié 2010Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-9-99
3,15 days_of_minimum_wageMedicine affordability for chemotherapy cycles in Kenya ranged from 3.15 to 162.42 days of minimum wage per cycle.
Kenyacancer (non précisé)PubMeddocument de 11 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.